Proxy Votes Now

Home › Funds › Brandes U.S. Value ETF

Brandes U.S. Value ETF (BUSA) proxy voting record 2025-2026

Fund family: 2023 ETF Series Trust · Filed by 2023 ETF Series Trust (CIK 1969674) · SEC series S000081644

Ticker: BUSA (C000244571)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 833 with, 42 against, 0 abstentions (not counted as with management). Shareholder proposals: 19 FOR, 23 AGAINST, 0 abstained, by the filing’s own vote-source field.

No item-level comparison with other 2023 ETF Series Trust funds is possible: no ballot item of this fund was voted by at least three other funds of the family with a clear majority.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 90.9% of this fund’s 875 such votes could be given a sector; the other 80 (9.1%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Finance197157.6%
Health Care14696.2%
Consumer Discretionary13975.0%
Technology11054.5%
Industrials7111.4%
Energy6035.0%
Consumer Staples4412.3%
Telecommunications1417.1%
Utilities1400.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections6430
Say-on-Pay620
Audit-related610
Compensation330
Corporate Governance2714
Shareholder Rights and Defenses1911
Capital Structure120
Environment or Climate66
Other Social Issues66
Human Rights or Human Capital/workforce33

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Micron Technology, Inc.January 15, 2026$12M121
Merck & Co., Inc.May 26, 2026$9M183
Cardinal Health, Inc.November 5, 2025$9M140
Citigroup Inc.May 20, 2026$8M160
The Cigna GroupApril 22, 2026$7M151
Pfizer Inc.April 23, 2026$7M161
Johnson & JohnsonApril 23, 2026$7M151
Textron Inc.April 29, 2026$7M130

Notable votes against management

MeetingCompanyProposalFundMgmt
January 15, 2026Micron Technology, Inc.Shareholder Proposal Requesting Amendment To Shareholder Special Meeting Right. Shareholder proposalForAgainst
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposalAgainstFor
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposalAgainstFor
April 22, 2026The Cigna GroupShareholder Proposal - Shareholder Right to Act by Written Consent Shareholder proposalForAgainst
April 23, 2026Pfizer Inc.Adopt an Independent Chair Policy Shareholder proposalForAgainst
April 23, 2026Johnson & JohnsonIndependent Board Chair Shareholder proposalForAgainst
May 27, 2026Chevron CorporationAdopt an Independent Chair Shareholder proposalForAgainst
May 27, 2026Chevron CorporationReport on Indigenous Peoples Rights Shareholder proposalAgainstFor
May 4, 2026Bank of America CorporationShareholder proposal requesting independent board chair Shareholder proposalAgainstFor
May 4, 2026Bank of America CorporationShareholder proposal requesting report on board oversight of risks related to animal welfare Shareholder proposalAgainstFor
April 28, 2026Wells Fargo & CompanyShareholder Proposal - Request for Board of Directors to Adopt Policy for an Independent Chair. Shareholder proposalAgainstFor
April 28, 2026Wells Fargo & CompanyShareholder Proposal - Govern by Majority Vote. Shareholder proposalAgainstFor

Search this fund’s votes by company

876 ballot items at 66 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Brandes U.S. Value ETF (BUSA) voted at 66 shareholder meetings of 62 companies, on 876 ballot items in all. Where management made a recommendation, the fund followed it on 95.2% of the items and voted against it 42 times. Its most frequent area of disagreement was corporate governance (14 of its votes against management). It voted on 42 shareholder proposals.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.